Taken together, these results indicate that DHI affects PI3K/AKT and ERK pathways in a cell-type-dependent manner and the common pathway affected by DHI in NHL cells is the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is non-Hodgkin lymphoma.